“Comparison Study of the Effect of Erlotinib As a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy”. Ibn AL-Haitham Journal For Pure and Applied Sciences 31, no. 3 (November 19, 2018): 63–69. Accessed May 7, 2024. https://jih.uobaghdad.edu.iq/index.php/j/article/view/2011.